Table 1 Clinical characteristics of the participants (means ± S.D.).
Characteristic | AF group (n = 49) | non-AF group (n = 116) | P value |
|---|---|---|---|
Age (years) | 55.56 ± 9.31 | 54.31 ± 13.01 | 0.619 |
Male, n (%) | 27 (55.10) | 89 (76.72) | 0.000 |
BMI (kg/m2) | 24.17 ± 3.69 | 24.55 ± 3.77 | 0.550 |
HR (beats/min) | 80.04 ± 11.87 | 73.24 ± 10.08 | 0.000 |
Diastolic pressure (mmHg) | 73.65 ± 17.28 | 71.32 ± 11.60 | 0.620 |
Systolic pressure (mmHg) | 118.85 ± 15.67 | 124.28 ± 16.94 | 0.042 |
EF% | 61.93 ± 10.27 | 59.51 ± 10.53 | 0.140 |
LAD (mm) | 51.83 ± 13.33 | 38.77 ± 7.82 | 0.000 |
LVEDD (mm) | 51.50 ± 10.73 | 54.70 ± 10.96 | 0.066 |
Creatinine (μmol/L) | 80.25 ± 20.56 | 79.44 ± 19.70 | 0.720 |
Ccr (ml/min) | 81.28 ± 21.34 | 94.24 ± 38.85 | 0.023 |
Hypertension, n (%) | 15 (30.61) | 43 (37.07) | 0.427 |
Heart failure history, n (%) | 19 (38.78) | 23 (19.83) | 0.011 |
COPD, n (%) | 2 (4.08) | 2 (1.72) | 0.730 |
Diabetes, n (%) | 7 (14.29) | 21 (18.10) | 0.551 |
MACCE, n (%) | 11 (22.45) | 9 (7.76) | 0.008 |
NYHA classes, n (%) | 0.000 | ||
NYHA I | 2 (4.08) | 3 (2.59) | |
NYHA II | 12 (24.5) | 63 (54.31) | |
NYHA III | 32 (65.3) | 49 (49.24) | |
NYHA IV | 3 (6.12) | 1 (0.86) |
